BioXcel Therapeutics, Inc. BTAI
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| BioXcel Holdings, Inc. | Delaware | 0 | 8546750 | 0 | 8546750 | 8546750 | 29.2 % | 28/09/2023 |
| Vimal Mehta | United States | 955895 | 8548750 | 955895 | 8548750 | 9504645 | 32.5 % | 28/09/2023 |
| BioXcel LLC | Delaware | 0 | 8546750 | 0 | 8546750 | 8546750 | 29.2 % | 28/09/2023 |
| (1) BlackRock, Inc. | Delaware | 1404607 | 0 | 1462922 | 0 | 1462922 | 5.2 % | 03/02/2023 |
| Adage Capital Partners, L.P. | Delaware | 0 | 1548591 | 0 | 0 | 1548591 | 5.53 % | 02/02/2023 |
| Robert Atchinson | United States | 0 | 1548591 | 0 | 0 | 1548591 | 5.53 % | 02/02/2023 |
| Phillip Gross | United States | 0 | 1548591 | 0 | 0 | 1548591 | 5.53 % | 02/02/2023 |
| Adage Capital Partners GP, L.L.C. | Delaware | 0 | 1548591 | 0 | 0 | 1548591 | 5.53 % | 02/02/2023 |
| Adage Capital Advisors, L.L.C. | Delaware | 0 | 1548591 | 0 | 0 | 1548591 | 5.53 % | 02/02/2023 |
| 13-4064930 | Delaware | 1461036 | 0 | 1489571 | 0 | 1508768 | 5.4 % | 14/02/2022 |
| STATE STREET CORPORATION | 0 | 1317336 | 0 | 1345096 | 1345096 | 4.81 % | 09/02/2022 | |
| Vimal Mehta | United States | 613001 | 9022000 | 613001 | 0 | 9635001 | 38.59 % | 16/02/2021 |
| Krishnan Nandabalan | United States | 478063 | 9021000 | 478063 | 0 | 9499063 | 38.23 % | 16/02/2021 |
| BioXcel LLC | Delaware | 0 | 9020000 | 0 | 0 | 9020000 | 37.02 % | 16/02/2021 |
| BioXcel Holdings, Inc. | Delaware | 0 | 9020000 | 0 | 0 | 9020000 | 37.02 % | 16/02/2021 |
| SSGA FUNDS MANAGEMENT, INC. | BOSTON, MASSACHUSETTS | 0 | 1467307 | 0 | 1469807 | 1469807 | 6.03 % | 11/02/2021 |
| STATE STREET CORPORATION | BOSTON, MASSACHUSETTS | 0 | 1631188 | 0 | 1673996 | 1673996 | 6.87 % | 11/02/2021 |
| FMR LLC | Delaware | 0 | 0 | 1666666 | 0 | 1666666 | 10.652 % | 10/04/2018 |